| 56 |
Entgegengehaltene Nichtpatentliteratur/Zitate,
vom Anmelder genannt |
CTNP |
A. GALKIN; X. F. LU; D. DUNAWAY-MARIANO; O. HERZBERG, JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 280, no. 40, 2005, pages 34080 - 34087 1;
ARCHIBALD RM: "Detemination of citrulline and allantoin and demonstration of citrulline in blood plasma", J BIOL CHEM, vol. 156, no. 1, 1944, pages 121 - 42 1;
BESSLER C; SCHMITT J; MAURER KH; SCHMID RD: "Directed evolution of a bacterial alpha- araylase: Toward enhanced pH-performance and higher specific activity", PROTEIN SCI, vol. 12, no. 10, 2003, pages 2141 - 9 1;
BOYDE TRC; RAHMATULLAH M: "Optimization of conditions for the calorimetric determination of citrulline, using diacetyl monoxime", ANAL BIOCHEM, vol. 107, no. 2, 1980, pages 424 - 31 1;
C. M. ENSOR; F. W. HOLTSBERG; J. S. BOMALASKI; M. A. CLARK, CANCER RESEARCH, vol. 62, no. 19, 2002, pages 5443 - 5450 1;
CHUANG VTG; KRAGH-HANSEN U; OTAGIRI M: "Pharmaceutical strategies utilizing recombinant human serum albumin", PHARM RES, vol. 19, no. 5, 2002, pages 569 - 77 1;
ENSOR CM; HOLTSBERG W; BOMALASKI JS; CLARK MA: "Pegylated arginine deiminase (ADI-SS PEG (20,000) (mw)) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo", CANCER RES, vol. 62, no. 19, 2002, pages 5443 - 50 1;
FANG TY; FORD C: "Protein engineering of Aspergillus awamori glucoamylase to increase its pH optimum", PROTEIN ENG, vol. 11, no. 5, 1998, pages 383 - 8 1;
GALKIN A; LU XF; DUNAWAY-MARIANO D; HERZBERG O: "Crystal structures representing the Michaelis complex and the thiouronium reaction intermediate of Pseudomonas aeruginosa arginine deiminase", J BIOL CHEM, vol. 280, no. 40, 2005, pages 3408E7 1;
GLIEDER A; FARINAS ET; ARNOLD FH: "Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase", NAT BIOTECHNOL, vol. 20, no. 11, 2002, pages 1135 - 9 1;
GONG H; ZOLZER F; VON RECKLINGHAUSEN G; HAVERS W; SCHWEIGERER L: "Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis", LEUKEMIA, vol. 14, no. 5, 2000, pages 826 - 9 1;
GUEX N; PEITSCH MC: "SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling", ELECTROPHORESIS, vol. 18, no. 15, 1997, pages 2714 - 23 1;
H. GONG; F. ZOLZER; G. VON RECKLINGHAUSEN; J. ROSSLER; S. BREIT; W. HAVERS; T. FOTSIS; L. SCHWEIGERER, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 261, no. 1, 1999, pages 10 - 14 1;
H. TAKAKU; M. TAKASE; S. ABE; H. HAYASHI; K. MIYAZAKI, INTERNATIONAL JOURNAL OF CANCER, vol. 51, no. 2, 1992, pages 244 - 249 1;
HIRATA A; ADACHI M; UTSUMI S; MIKAMI B: "Engineering of the pH optimum of Bacillus cereus beta-amylase: Conversion of the pH optimum from a bacterial type to a higher-plant type", BIOCHEMISTRY (MOSC), vol. 43, no. 39, 2004, pages 12523 - 31 1;
HOLTSBERG RN; ENSOR CM; STEINER MR; BORNALASKI JS; CLARK MA: "Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties", J CONTROLLED RELEASE, vol. 80, no. 1-3, 2002, pages 259 - 71 1;
IZZO F; MARRA P; BENEDUCE G ET AL.: "Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: Results from phase I/II studies", J CLIN ONCOL., vol. 22, no. 10, 2004, pages 5181 - 22 1;
J. D. FENSKE; G. E. KENNY, JOURNAL OF BACTERIOLOGY, vol. 126, no. 1, 1976, pages 501 - 510 1;
J. E. KIM; D. W. JEONG; H. J. LEE, PROTEIN EXPRESSION AND PURIFICATION, vol. 53, no. 1, 2007, pages 9 - 15 1;
K. BELOUSSOW; L. WANG; J. WU; D. ANN, W. C. SHEN, CANCER LETTERS, vol. 183, no. 2, 2002, pages 155 - 162 1;
L. L. ZHU; K. L. TEE; D. ROCCATANO; B. SONMEZ; Y. NI; Z. H. SUN; U. SCHWANEBERG, CHEMBIOCHEM, vol. 11, no. 5, 2010, pages 691 - 697 1;
LI L; LI ZM; WANG CH ET AL.: "The electrostatic driving force for nucleophilic catalysis in L-arginine deiminase: a combined experimental and theoretical study", BLOCHEMISTRY (MOSC), vol. 47, no. 16, 2008, pages 4721 - 32 1;
LU XF; LI L; WU R ET AL.: "Kinetic analysis of Pseudomonas aeruginosa arginine deiminase mutants and alternate substrates provides insight into structural determinants of function", BIOCHEMISTRY (MOSC), vol. 45, no. 4, 2006, pages 62 - 72 1;
M. KUNDU; J. THOMAS; A. M. FIALHO; J. M. KWAN; L. M. MOREIRA; M. MAHFOUZ; T. K. DAS GUPTA; A. M. CHAKRABARTY, LETTERS IN DRUG DESIGN & DISCOVERY, vol. 6, no. 6, 2009, pages 403 - 412 1;
MIYAZAKI K; TAKENOUCHI M: "Creating random mutagenesis libraries using megaprimer PCR of whole plasmid", BIOTECHNIQUES, vol. 33, no. 5, 2002, pages 1033 - 8 1;
MULLER HJ; BOOS J: "Use of L-asparaginase in childhood all", CRIT REV ONCOL HEMATOL., vol. 28, no. 2, 1998, pages 97 - 1 13 1;
NI Y; SCHWANEBERG U; SUN ZH: "Arginine deiminase, a potential anti-tumor drug", CANCER LETT, vol. 261, no. 1, 2008, pages 1 - 1 1 1;
PARK IS; KANG SW; SHIN YJ ET AL.: "Arginine deiminase: a potential inhibitor of angiogenesis and tumour growth", BR J CANCER, vol. B9, no. 5, 2003, pages 907 - 14 1;
R. HARASAWA; K. KOSHIMIZU; M. KITAGAWA; K. ASADA; I. KATO, MICROBIOLOGY AND IMMUNOLOGY, vol. 36, no. 6, 1992, pages 661 - 665 1;
S. MISAWA; M. AOSHIMA; H. TAKAKU; M. MATSUMOTO; H. HAYASHI, JOURNAL OF BIOTECHNOLOGY, vol. 36, no. 2, 1994, pages 145 - 155 1;
SAKODA H; IMANAKA T: "Cloning and sequencing of the gene coding for alcohol- dehydrogenase of Bacillus stearothermophilus and rational shift of the optimum pH", J BACTE- RIOL, vol. 174, no. 4, 1992, pages 1397 - 402 1;
SHEN W; SHEN WC: "Drug evaluation: ADI-PEG-20 - a PEGylated arginine deiminase for arginine auxotrophic cancers", CURR OPIN IN MOL THER, vol. 8, no. 3, 2006, pages 240 - 8 1;
STEMMER WPC: "Rapid evolution of a protein in vitro by DNA shuffling", NATURE, vol. 370, no. 6488, 1994, pages 389 - 91 1;
STEPHEN F. ALTSCHUL; THOMAS L. MADDEN; ALEJANDRO A. SCHÄFFER; JINGHUI ZHANG; ZHENG ZHANG; WEBB MILLER; DAVID J. LIPMAN: "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402 1;
STUDIER FW: "Protein production by auto-induction in high-density shaking cultures", PROTEIN EXPRESSION PURIF, vol. 41, no. 1, 2005, pages 207 - 34 1;
TAKAKU ET AL., INT. J: CANCER, vol. 51, 1992, pages 244 - 249 1;
TAKAKU H; MATSUMOTO M; MISAWA S; MIYAZAKI K: "Antitumor-activity of arginine deiminase from Mycoplasma arginini and its growth-Inhibitory mechanism", JAP J CANCER RES, vol. 86, no. 9, 1995, pages 840 - 6 1;
TEE KL; DMYTRENKO 0; OTTO K; SCHMID A; SCHWANEBERG U: "A p-nitrothiophenolate screening system for the directed evolution of a two-component epoxygenase (StyAB)", J MOL CATAL B: ENZYM, vol. 50, no. 2-4, 2008, pages 121 - 7 1;
TOMSCHY A.; BRUGGER R.; LEHMANN M ET AL.: "Engineering of phytase for improved activity at low pH", APPL ENVIRON MICROBIOL, vol. 68, no. 4, 2002, pages 1907 - 13 1;
TURUNEN O.; JANIS J; FENEL F; LEISOLA M: "Engineering the thermotolerance and pH optimum of family 11 xylanases by site-directed mutagenesis", METHODS ENZYMOL, vol. 388, 2004, pages 156 - 67 1;
VAN GUNSTEREN WF; BILLETER SR; EISING AA ET AL.: "Bimolecular simulation: the gromos 96 manual and user guide", ETH ZURICH, 1996 1;
WANG WY; MALCOLM BA: "Two-stage PCR protocol allowing introduction of multiple mutations, deletions and insertions using QulkChangeTM site-directed mutagenesis", BIOTECHNIQUES, vol. 26, no. 4, 1999, pages 680 - 2 1;
WONG TS; ARNOLD FH; SCHWANEBERG U: "Laboratory evolution of cytochrome P450BM-3 monooxygenase for organic cosolvents", BIOTECHNOL BIOENG, vol. 85, no. 3, 2004, pages 351 - 8 1;
Y. Z. WEI; H. ZHOU; Y. SUN; Y. B. HE; Y. Z. LUO, PROTEINS-STRUCTURE FUNCTION AND BIOIN- FORMATICS, vol. 66, no. 3, 2007, pages 740 - 750 1;
ZHU ZW; MOMEU C; ZAKHARTSEV M; SCHWANEBERG U: "Making glucose oxidase fit for biofuel cell applications by directed protein evolution", BIOSENS BIOELECTRON, vol. 21, no. 15, 2006, pages 2046 - 51 1
|
